These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Still hope for schistosomiasis vaccine. Ricciardi A; Ndao M Hum Vaccin Immunother; 2015; 11(10):2504-8. PubMed ID: 26176659 [TBL] [Abstract][Full Text] [Related]
3. Egypt's schistosomiasis control programme in the 1980s prepared the ground for the global elimination of schistosomiasis by 2030. Fenwick A Trans R Soc Trop Med Hyg; 2019 Jan; 113(1):1-3. PubMed ID: 31222345 [TBL] [Abstract][Full Text] [Related]
4. Immunological Considerations for Driciru E; Koopman JPR; Cose S; Siddiqui AA; Yazdanbakhsh M; Elliott AM; Roestenberg M Front Immunol; 2021; 12():635985. PubMed ID: 33746974 [TBL] [Abstract][Full Text] [Related]
6. A worm vaccine, coming at a snail's pace. Kupferschmidt K Science; 2013 Feb; 339(6119):502-3. PubMed ID: 23371989 [No Abstract] [Full Text] [Related]
7. Current status of vaccines for schistosomiasis. McManus DP; Loukas A Clin Microbiol Rev; 2008 Jan; 21(1):225-42. PubMed ID: 18202444 [TBL] [Abstract][Full Text] [Related]
8. Towards elimination of schistosomiasis after 5000 years of endemicity in Egypt. Abou-El-Naga IF Acta Trop; 2018 May; 181():112-121. PubMed ID: 29453950 [TBL] [Abstract][Full Text] [Related]
9. Blueprint for schistosomiasis vaccine development. Bergquist R; Al-Sherbiny M; Barakat R; Olds R Acta Trop; 2002 May; 82(2):183-92. PubMed ID: 12020891 [TBL] [Abstract][Full Text] [Related]
10. Progress towards a vaccine for schistosomiasis. Pearce EJ Acta Trop; 2003 May; 86(2-3):309-13. PubMed ID: 12745147 [TBL] [Abstract][Full Text] [Related]
11. Schistosoma spp.: progress toward a defined vaccine. James SL Exp Parasitol; 1987 Jun; 63(3):247-52. PubMed ID: 3108024 [TBL] [Abstract][Full Text] [Related]
12. Schistosomiasis vaccines: where do we stand? Tebeje BM; Harvie M; You H; Loukas A; McManus DP Parasit Vectors; 2016 Sep; 9(1):528. PubMed ID: 27716365 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneities in anti-schistosome humoral responses following chemotherapy. Mutapi F Trends Parasitol; 2001 Nov; 17(11):518-24. PubMed ID: 11872396 [TBL] [Abstract][Full Text] [Related]
14. Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? Bergquist R; Utzinger J; Keiser J Infect Dis Poverty; 2017 Mar; 6(1):74. PubMed ID: 28351414 [TBL] [Abstract][Full Text] [Related]
15. Advancing a vaccine to prevent human schistosomiasis. Merrifield M; Hotez PJ; Beaumier CM; Gillespie P; Strych U; Hayward T; Bottazzi ME Vaccine; 2016 Jun; 34(26):2988-2991. PubMed ID: 27036511 [TBL] [Abstract][Full Text] [Related]
17. Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis. Chura-Chambi RM; Nakajima E; de Carvalho RR; Miyasato PA; Oliveira SC; Morganti L; Martins EA J Biotechnol; 2013 Dec; 168(4):511-9. PubMed ID: 24084635 [TBL] [Abstract][Full Text] [Related]
18. Influence of schistosomiasis on host vaccine responses. Nono JK; Kamdem SD; Musaigwa F; Nnaji CA; Brombacher F Trends Parasitol; 2022 Jan; 38(1):67-79. PubMed ID: 34389214 [TBL] [Abstract][Full Text] [Related]
19. Can schistosomiasis really be consigned to history without a vaccine? Bethony JM; Diemert DJ; Oliveira SC; Loukas A Vaccine; 2008 Jun; 26(27-28):3373-6. PubMed ID: 18513839 [TBL] [Abstract][Full Text] [Related]